|
AU2004238253A1
|
|
Controlled release formulation of erythromycin derivatives
|
|
AU2003225649A1
|
|
Control release formulation containing a hydrophobic material as the sustained release agent
|
|
US2003077324A1
|
|
Control release formulation containing a hydrophobic material as the sustained release agent
|
|
EP1385486A1
|
|
A novel coating for a sustained release pharmaceutical composition
|
|
US7179486B1
|
|
Process for preparing sustained release tablets
|
|
BR0013719A
|
|
Controlled-release oral dosage, suitable for oral administration
|
|
WO0115668A1
|
|
Controlled release pellet formulation
|
|
NZ512288A
|
|
Sustained release tablet containing hydrocolloid and cellulose ether
|
